Mkts

Nutex Health Inc.

NASDAQ: NUTX
$171.33-3.18 (-1.82%)
As of Nov 18, 2:26 PM ET

Key statistics

Day range
170.40180.44
52-week range
83.99226.16
Today
Open174.49
Previous close171.33
Volume79.9K
Valuation
Market cap1.19B
P/E ratio6.61×
EPS (TTM)25.29
Income & risk
Dividend / yield—
Beta0.78
Avg volume148.4K
Discussion

NUTX News

Stories mentioning NUTX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue216,485151,679267,804243,985211,789257,61878,79576,082
Cost of Goods Sold
Gross Profit91,73046,138154,881124,924118,338141,62621,91722,561
Operating Expenses
Research & Development
Sales General & Admin
Total Operating Expenses10,46515,22024,51491,24537,67727,41712,25417,262
Operating Income (Loss)81,26530,918130,36733,67980,661114,2099,6635,299
Interest Income
Interest Expense
Other Expense(23.00)(48.00)(976.00)(4,269)(3,325)(43.00)(128.00)599.00
Pretax Income76,56025,894123,93923,73271,216108,578(2,580)3,904
Tax Provision13,7979,28627,1407,58820,4108,6094,585894.00
Net Income (Loss)46,80711,83455,435(17,697)21,21761,696(8,788)(364.00)
Earnings Per Share (Basic)6.701.868.27(2.95)3.7411.83(1.72)(0.07)
Earnings Per Share (Diluted)6.521.757.76(2.95)3.3311.12(1.72)(0.07)
Weighted Average Shares Outstanding (Basic)6,9906,3616,7015,9955,6675,0915,1004,970
Weighted Average Shares Outstanding (Diluted)7,1796,7567,1785,9956,4515,4925,1004,970

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About NUTX

Nutex Health Inc. (NASDAQ: NUTX) is a stock listed on the Nasdaq Stock Market under the ticker symbol NUTX. It last traded at $171.33 (Nov 18, 2026, 2:26 PM ET), down 1.8% on the day. That gives Nutex Health a market capitalisation of $1.2B and a price-to-earnings ratio of 6.6.

Over the past 52 weeks NUTX has traded between $83.99 and $226.16.

Revenue for the quarter ended Mar 31, 2026 was $216.5M; net income $46.8M. Revenue was up 2.2% from $211.8M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$216.5M$46.8M21.6%
Dec 31, 2025$151.7M$11.8M7.8%
Sep 30, 2025$267.8M$55.4M20.7%
Jun 30, 2025$244.0M-$17.7M-7.3%

From Nutex Health’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…